Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

MediPharm and TerrAscend Sign Cannabis Extraction Agreement

Stockhouse Editorial
0 Comments| January 9, 2019

Canadian research-driven cannabis extraction Company MediPharm Labs Inc. (TSX-V: LABS, OTCQB:MLCPF, Forum) said this week that it has entered into an initial three-year extraction agreement for to process dried cannabis to cannabis oil concentrates with TerrAscend Corp. (CSE: TER). MediPharm is working to scale its business to 250,000 kg. of dried cannabis extraction capacity annually.

For more information on this, click here.

Earlier this week, MediPharm also made news when its shares began trading on the OTCQB market.

FULL DISCLOSURE: MediPharm Labs Inc. is a client of Stockhouse Publishing.

Interested in these industries and sectors?

Receive investor kits and email updates from Stockhouse and directly from these companies.

Metals & Mining

Interested in these industries and sectors?

You are already a member! Please enter your password to sign in.


No comments yet. Be first to comment!

Leave a Comment

You must be logged in to access this feature.


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.